¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mutation rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • suppressor mutation
    ¾ïÁ¦(µ¹¿¬)º¯ÀÌ
  • temperature-sensitive mutation
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌ
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • attack rate
    ¹ßº´·ü
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü
  • abortion rate
    À¯»êÀ²
  • age-specific death rate
    ¿¬·Éº°»ç¸Á·ü
  • age-specific fertility rate
    ¿¬·Éº°»ý½Ä·ü
  • age-specific rate
    ¿¬·Éº°ºñÀ²
  • absorbed dose rate
    Èí¼ö¼±·®·ü
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âÀ², ÇãÆÄ²Ê¸®È¯±âÀ²
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • bed turnover rate
    º´»óȸÀüÀ²
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • onset rate
    ¹ß»ý·ü
  • operative mortality rate
    ¼ö¼ú»ç¸Á·ü
  • peak expiratory flow rate
    ÃÖ°í³¯¼û¼Óµµ, ÃÖ°íÈ£±âÀ¯¼Ó
  • perfusion rate
    °ü·ù¼Óµµ, °ü·ùÀ²
  • pregnancy rate
    Àӽŷü
  • prevalence rate
    À¯º´·ü
  • pulse rate
    ¸Æ¹Ú¼ö
  • relaxation rate
    À̿Ϸü
  • respiratory rate
    È£Èí¼öÈ£Èí·ü
  • response rate
    ¹ÝÀÀ·ü
  • standardized death rate
    Ç¥ÁØÈ­»ç¸Á·ü
  • survival rate
    »ýÁ¸·ü
  • tidal rate
    È£Èí¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • reversible mutation
    µÇÁý±âµ¹¿¬º¯ÀÌ, °¡¿ªµ¹¿¬º¯ÀÌ
  • somatic mutation
    ü¼¼Æ÷µ¹¿¬º¯ÀÌ
  • spontaneous mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • suppression mutation
    ¾ïÁ¦µ¹¿¬º¯ÀÌ
  • temperature-sensitive mutation
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌ
  • voice mutation
    º¯¼º
  • somatic mutation theory
    ü¼¼Æ÷µ¹¿¬º¯À̼³
  • abortion rate
    À¯»êÀ²
  • absorbed dose rate
    Èí¼ö¼±·®·ü
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • age-specific rate
    ¿¬·Éº°Æ¯¼öÀ²
  • age-specific death rate
    ¿¬·Éº°Æ¯¼ö»ç¸Á·ü
  • age-specific fertility rate
    ¿¬·Éº°Ãâ»êÀ²
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • glomerular filtration rate
    »ç±¸Ã¼ ¿©°úÀ²
  • glomerular filtration rate
    »ç±¸Ã¼¿©°úÀ²
  • glomerular filtration rate =GFR
    »ç±¸Ã¼¿©°úÀ²(¡­ÕëΦëÏ).
  • glomerular filtration rate =GFR
    »ç±¸Ã¼¿©°úÀ².
  • gross reproduction rate
    ÃÑÀç»ý»êÀ².
  • growth rate
    ¼ºÀå·ü(ËÛËöËô).
  • growth rate constant
    Áõ½Ä·ü»ó¼ö
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • heart rate
    ½É¹Ú¼ö, ½É(Àå)¹Úµ¿¼ö(ãýíôÚÑÔÑâ¦).
  • heart rate meter
    ½É¹Ú°è(ãýÚÑͪ), ½É(Àå)¹Úµ¿°è(ãýíôÚÑÔÑͪ)
  • heat transfer rate
    ¿­Àü´Þ·ü(¡­ëÒ).
  • heat transfer rate
    ¿­Àü´Þ·ü(ÊÙËô).
  • hebdomadal death rate
    »ýÈÄÀÏÁÖ°£»ç¸Á·ü(ÊÙË×ËÎËô).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mutation disturbance
    º¯¼ºÀå¾Ö(ܨàõî¡äô).
  • mutation genetics
    º¯ÀÌÀ¯ÀüÇÐ(ܨì¶ë¶îîùÊ).
  • mutation, back
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • mutation, chromosomal
    ¿°»öüµ¹¿¬º¯ÀÌ
  • mutation, dominant
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • mutation, extragenic suppressor
    À¯ÀüÀÚ¿Ü ¹ßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
  • mutation, forward
    ÀüÇâ µ¹¿¬º¯ÀÌ
  • mutation, frame-shift
    ÇØµ¶Æ² µ¹¿¬º¯ÀÌ, ÇÁ·¹ÀÓ½¬ÇÁÆ® µ¹¿¬º¯ÀÌ
  • mutation, missense
    °ú¿À µ¹¿¬º¯ÀÌ, ¹Ì¼¾½º µ¹¿¬º¯ÀÌ
  • mutation, nonsense
    ¹«ÀÇ¹Ì µ¹¿¬º¯ÀÌ, ³­¼¾½º µ¹¿¬º¯ÀÌ
  • mutation, plaque-type
    ÇöóÅ©Çü µ¹¿¬º¯ÀÌ
  • mutation, point
    Á¡ µ¹¿¬º¯ÀÌ
  • mutation, polar
    ±Ø¼ºÈ¿°ú°¡ ³ª´Âµ¹¿¬º¯ÀÌ
  • mutation, reading frame
    ÇØµ¶Æ² µ¹¿¬º¯ÀÌ
  • mutation, recessive
    ¿­¼º µ¹¿¬º¯ÀÌ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lethal mutation
    Ä¡»çº¯ÀÌ(öÈÞÝܨì¶)
  • lethal mutation model
    Ä¡»çº¯ÀÌ(öÈÞÝܨì¶)¸ðµ¨
  • missense mutation
    ¿ÀÀκ¯ÀÌ(è¦ìãܨì¶)
  • mutation
    º¯ÀÌ(ܨì¶)
  • mutation distance
    º¯ÀÌ(ܨì¶)°Å¸®
  • mutation frequency
    º¯À̺óµµ(ܨì¶ÞºÓø)
  • mutation index
    º¯ÀÌÁö¼ö(ܨì¶ò¦â¦)
  • mutation stabilization
    º¯À̾ÈÁ¤È­(ܨì¶äÌïÒûù)
  • mutation theory
    º¯ÀÌ·Ð(ܨì¶Öå)
  • neutral mutation
    Á߸³º¯ÀÌ(ñ騡܍ì¶)
  • nonsense mutation
    ³Í¼¾½º º¯ÀÌ(ܨì¶)
  • ochre mutation
    ¿À¿ìÄ¿º¯ÀÌ(ܨì¶)
  • phase shift mutation
    »óÀ̵¿ º¯ÀÌ(ßÓì¹ÔÑܨì¶)
  • pleiotropic mutation
    ´ÙÇüÁú¼º º¯ÀÌ(Òýû¡òõàõܨì¶)
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
RR radiation reaction; radiation response; rate ratio; rational recovery [group]; recovery room; relati...
Sed. Rate Sedimentation Rate; ħ°­ ¼Óµµ
  = SR
SR   1) Sinus Rhythm
  2) Sedimentation Rate; ħ°­ ¼Óµµ
    =...
AER abduction/external rotation; acoustic evoked response; acute exertional rhabdomyolysis; agranular en...
AMR acoustic muscle reflex; activity metabolic rate; acute mitral stenosis; alopecia-mental retardation ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ASR Age standardised rate
AER Albumin Excretion Rate
ASR Aldosterone Secretion Rate
AR Attack Rate
ADMR Average daily metabolic rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • daily secretion rate
    ÀÏÀÏ ºÐºñ·®
  • diffusion rate
    È®»êÀ²
  • disappearance rate
    ¼Ò½Ç·ü
  • disintegration rate
    ºØ±«À²
  • DMF index rate
    µð¿¥¿¡ÇÁ Áö¼öÀ²
  • dosage rate
    ¼±·®·ü, ¿ë·®
  • dose rate effect
    ¼±·®À² È¿°ú
  • dose rate variation
    ¼±·®·ü º¯È­
  • elevated erythrocyte sedimentation rate
    Áõ°¡µÈ ÀûÇ÷±¸ ħ°­ ¼Óµµ
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸ ħ°­ ¼Óµµ
    ÀÀ°íµÇÁö ¾ÊÀº Ç÷¾×À» ´ãÀº °ü¿¡¼­ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â À²·Î¼­ ½Ã°£´ç mm·Î Ç¥½ÃÇÑ´Ù. ÀûÇ÷±¸ ħ°­ ¼ÓµµÀÇ Áõ°¡´Â ¿°ÁõÀÌ ÀÖ´Ù´Â °ÍÀ» ÀǹÌÇϳª Ưº°ÇÑ Àå¾Ö¿¡ ´ëÇØ °íÀ¯ÇÏÁö´Â ¾Ê´Ù.
  • fertility rate
    Ãâ»êÀ², ¼öÁ¤·ü
  • fractional fibrinogen catab rate
    ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ²
  • heart rate meter
    ½É¹Ú°è, ½ÉÀå ¹Úµ¿°è, ½É¹Úµ¿°è
  • hebdomadal death rate
    »ýÈÄ ÀÏ ÁÖ°£ »ç¸Á·ü
  • high repitition rate
    °í¹Ýº¹À², ³ôÀº ¹Ýº¹À²
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
deletion mutation <molecular biology> A mutation in which one or more (sequential) nucleotides is lost by the genome. If the number lost is not divisible by 3 and is in a coding region, the result is a frameshift mutation.
(18 Nov 1997)
down promoter mutation <molecular biology> A mutation (a change in base pair sequence) in a promoter region, this results in lower gene expression (less transcription of the gene occurs).
(09 Oct 1997)
induced mutation A mutation caused by exposure to a mutagen.
(05 Mar 2000)
insertion mutation A mutation caused by the insertion of at least one extra nucleotide basein a DNA sequence.
(09 Oct 1997)
ochre mutation Mutation that changes any codon to the termination codon UAA.
(18 Nov 1997)
opal mutation <molecular biology> Mutation that changes any codon to the termination codon UGA.
(18 Nov 1997)
temperature sensitive mutation <genetics, molecular biology> A type of conditional mutation in organism, somatic cell or virus that makes it possible to study genes whose total inactivation would be lethal. Such ts mutations can also make possible studies of the effect of reversible switching by temperature changes) in expression of the mutated gene. The usual mechanism of temperature sensitivity is that the mutated gene codes for a protein with a temperature dependent conformational instability, so that it possesses normal activity at one temperature (the permissive temperature), but is inactive at a second (nonpermissive) temperature.
(18 Nov 1997)
transition mutation A point mutation involving substitution of one base-pair for another, i.e., replacement of one purine for another and of one pyrimidine for another pyrimidine without change in the purine-pyrimidine orientation.
(05 Mar 2000)
transversion mutation A point mutation involving base substitution in which the orientation of purine and pyrimidine is reversed, in contradistinction to transition mutation.
(05 Mar 2000)
umber mutation A mutation yielding the termination codon UGA, resulting in premature termination of a polypeptide chain.
Compare: suppressor mutation.
Synonym: opal mutation.
(05 Mar 2000)
unstable mutation <molecular biology> A mutation that has a high likelihood of reverting to its original form.
(13 Nov 1997)
up mutation <molecular biology> Refers to any mutation in the promoter region of a gene which can trigger transcription initiation.
(09 Oct 1997)
up promoter mutation A mutation that increases the frequency of initiation of transcription.
(05 Mar 2000)
forward mutation Any mutation which renders a formerly functional gene nonfunctional.
Compare: back mutation.
(09 Oct 1997)
frameshift mutation <molecular biology> A type of mutation that results from insertion or deletion of a single nucleotide into, or from, an open reading frame in the normal DNA sequence.
Normally, the genetic code is read in the wrong frame, three nucleotides at a time, and the entire sequence downstream of the mutation, is translated into a polypeptide with a garbled amino acid sequence from the mutated codon onwards. These mutations may be induced by certain types of mutagens or may occur spontaneously and usually result in the generation, downstream, of nonsense, chain termination codons.
Synonym: addition mutation, addition-deletion mutation, deletion mutation, reading-frameshift mutation.
(21 Jun 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fixed exchange rate(system)
    °íÁ¤È¯½Ã¼¼(Á¦)
  • flat rate
    °íÁ¤(Á¤¾×)¿ä±Ý
  • floating exchange rate system
    º¯µ¿ ȯÀ²Á¦
  • floating rate
    ÀÚÀ¯ º¯µ¿ ½Ã¼¼;¼±Çϼ¼
  • forward rate
    (¿Ü±¹È¯ÀÇ) ¼±¹° ½Ã¼¼
  • freight rate
    ¿îÀÓ·ü Àå
  • fuel rate
    Ãʰ£ ¿¬·á ¼ÒºñÀ²
  • interest rate
    ±Ý¸®ÀÌÀ²
  • kill rate
    (ÀüÀï,Æøµ¿ µîÀÇ)»ì»ý·ü 9
  • milline rate
    1milline ´çÀÇ ±¤°í·á
  • minimum lending rate
    (¿µ)(À×±Û·£µå ÀºÇàÀÇ) ÃÖÀú ´ëÃ⠱ݸ®
  • poor rate
    ±¸ºó¼¼
  • prime rate
    (¹Ì±¹ ÀºÇàÀÌ 1·ù ±â¾÷¿¡ Àû¿äÇÏ´Â)Ç¥ÁØ ±Ý¸®
  • rate
    ºñÀ²;¿ä±Ý;½Ã¼¼;°¡°Ý;Æò°¡;¼Óµµ;Áøµµ;ÇÏ·çÀÇ ¿ÀÂ÷(½Ã°èÀÇ);¼¼±Ý;Áö¹æ¼¼;µî±Þ(¹è.¼±¿øÀÇ)...µî;Á¾·ù;Æò°¡ÇÏ´Ù;¾î¸²Àâ´Ù;...À¸·Î ¾Ë´Ù;À̶ó°í »ý°¢ÇÏ´Ù;(°ú¼¼¸¦ ¸ñÀûÀ¸·Î)...À» Æò°¡ÇÏ´Ù;...¿¡°Ô Áö¹æ¼¼¸¦ °úÇÏ´Ù;(¼±¿ø.¼±¹ÚÀÇ)µî±ÞÀ» Á¤ÇÏ´Ù;±Ô°ÝÀ» Á¤ÇÏ´Ù;(±â°èÀÇ)¿ÀÂ÷¸¦ Ãø
  • rate base
    (ÀâÁöÀÇ)º¸Áõ ºÎ¼ö(À̸¦ ¹ÙÅÁÀ¸·Î ±¤°í¿ä±ÝÀÌ Á¤ÇØÁü)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á